<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="371455">
  <stage>Registered</stage>
  <submitdate>6/09/2016</submitdate>
  <approvaldate>7/10/2016</approvaldate>
  <actrnumber>ACTRN12616001395426</actrnumber>
  <trial_identification>
    <studytitle>The  changes in serum potassium and blood sugar levels during heart  surgery</studytitle>
    <scientifictitle>Trend of changes in the intraoperative blood glucose and serum potassium levels of adult patients undergoing Off-Pump Coronary Artery Bypass surgeries</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>heart surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>36 adult patients of either sex undergoing elective off pump coronary bypass surgery (OPCAB) in Safdarjung hospital, New Delhi, India will be enrolled in this study. In the operation theatre, Etomidate/ Morphine ( 0.1 mg/kg) / Fentanyl (2 ug/kg) / vecuronium bromide (0.1mg/kg)/Oxygen/ Air will be used to induce anesthesia. Anesthesia will be maintained using oxygen/ air/ isoflurane and topups of vecuronium and morphine.  Arterial blood gas analysis will be done by the staff anesthesiologist at predetermined intra-operative time points to measure levels of blood glucose and serum potassium as primary variables. Base excess, pH and HCO3? will be recorded as secondary variables. The time intervals will be just after arterial cannulation (T0), just before grafting (T1), thereafter, every 30 min at 30 min ( T2), 60 min (T3), 90 min (T4), 120 min (T5), end of graft ( T6) and end of surgery (T7). Insulin infusion will be started according to the sliding scale, whenever blood glucose will be higher than 200 mg/dl. Potassium Chloride 5 ml will be supplemented whenever serum potassium will be lower than 4mEq/l. </interventions>
    <comparator>no control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>blood sugar levels will be measured intraoperatively at regular intervals</outcome>
      <timepoint>The time intervals will be just after arterial cannulation (T0), just before grafting (T1), thereafter, every 30 min ---at 30 min ( T2), 60 min (T3), 90 min (T4), 120 min (T5), end of graft (T6) and end of surgery (T7). </timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>serum potassium levels will be measured intraoperatively at regular intervals</outcome>
      <timepoint>The time intervals will be just after arterial cannulation (T0), just before grafting (T1), thereafter, every 30 min ---at 30 min ( T2), 60 min (T3), 90 min (T4), 120 min (T5), end of graft (T6) and end of surgery (T7). </timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>serum pH variation with time will be measured intraoperatively </outcome>
      <timepoint>The time intervals will be just after arterial cannulation (T0), just before grafting (T1), thereafter, every 30 min ----at 30 min (T2), 60 min (T3), 90 min (T4), 120 min (T5), end of graft (T6) and end of surgery (T7). </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>serum HCO3 variation with time will be measured intraoperatively</outcome>
      <timepoint>The time intervals will be just after arterial cannulation (T0), just before grafting (T1), thereafter, every 30 min ----at 30 min (T2), 60 min (T3), 90 min (T4), 120 min (T5), end of graft (T6) and end of surgery (T7). </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>serum base excess levels will be measured intraoperatively</outcome>
      <timepoint>The time intervals will be just after arterial cannulation (T0), just before grafting (T1), thereafter, every 30 min ----at 30 min (T2), 60 min (T3), 90 min (T4), 120 min (T5), end of graft (T6) and end of surgery (T7). </timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients of either sex,  undergoing CABG</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Any liver/ renal abnormality </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>14/10/2016</anticipatedstartdate>
    <actualstartdate>14/10/2016</actualstartdate>
    <anticipatedenddate>31/12/2016</anticipatedenddate>
    <actualenddate>28/02/2017</actualenddate>
    <samplesize>36</samplesize>
    <actualsamplesize>36</actualsamplesize>
    <currentsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>3/03/2017</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>India</country>
      <state>delhi</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>safdarjung hospital</primarysponsorname>
    <primarysponsoraddress>Safdarjung hospital,Ring road, New Delhi, Delhi, India- 110029</primarysponsoraddress>
    <primarysponsorcountry>India</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>safdarjung hospital</fundingname>
      <fundingaddress>Safdarjung hospital,Ring road, New Delhi, Delhi, India- 110029</fundingaddress>
      <fundingcountry>India</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Background: Intra-operative levels of blood glucose and serum potassium often vary with the duration of off-pump coronary artery bypass (OPCAB) surgery. Aim: In this study, we will analyze the trend of changes in the intra-operative levels of blood glucose and serum potassium in adult patients undergoing elective OPCAB surgery. This will improve management as well as reduce complications of OPCAB surgeries. Method: 36 adult patients of either sex undergoing elective OPCAB will be enrolled in this study in safdarjung hospital, new delhi, India.. Blood gas analysis will be done at predetermined intra-operative time points to measure levels of blood glucose and serum potassium as primary variables. Base excess, PH and HCO3 will be recorded as secondary variables. Insulin infusion will be started according to sliding scale,  whenever blood glucose increases greater than 200 mg/dl. Intravenous potassium will be  supplemented, whenever serum potassium measured less than 4mEq/l. </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>vardhaman mahavir medical college &amp; safdarjung hospital ethics committee</ethicname>
      <ethicaddress>vardhaman mahavir medical college &amp; Safdarjung hospital,Ring road, New Delhi, Delhi, India- 110029</ethicaddress>
      <ethicapprovaldate>16/05/2016</ethicapprovaldate>
      <hrec>IEC -596</hrec>
      <ethicsubmitdate>8/02/2016</ethicsubmitdate>
      <ethiccountry>India</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>kapil gupta</name>
      <address>Associate professor, department of anesthesia 
vardhaman mahavir medical college &amp; safdarjung hospital,
Ring Road,New delhi,
 Delhi,
 India- 110029</address>
      <phone>+91-9811859019</phone>
      <fax />
      <email>kapgup11@yahoo.co.in</email>
      <country>India</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name> kapil gupta</name>
      <address>Associate professor, department of anesthesia 
vardhaman mahavir medical college &amp; safdarjung hospital,
Ring Road,New delhi,
 Delhi,
 India- 110029</address>
      <phone>+91-9811859019</phone>
      <fax />
      <email>kapgup11@yahoo.co.in</email>
      <country>India</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name> kapil gupta</name>
      <address>Associate professor, department of anesthesia 
vardhaman mahavir medical college &amp; safdarjung hospital,
Ring Road,New delhi,
 Delhi,
 India- 110029</address>
      <phone>+91-9811859019</phone>
      <fax />
      <email>kapgup11@yahoo.co.in</email>
      <country>India</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>